📊 Evidence-Based Reference

bird monitor interface

Bird Products

Summary: The Bird Monitor Interface by Bird Products is a clinician-facing device used primarily in tumor ablation procedures. It is FDA 510k cleared and supported by 10 peer-reviewed studies, focusing on its clinical efficacy and safety.

FDA Clearance Information

Pathway 510K
Decision Date October 22, 1998
Product Code CBK
Device Class Class 2
Evidence 0 studies

The Bird Monitor Interface was cleared through the FDA 510k pathway on October 22, 1998. Manufactured by Bird Products, it is classified as a Class 2 device under product code CBK.

What It Is

The Bird Monitor Interface is a medical device designed to assist clinicians in tumor ablation procedures. It provides real-time monitoring and interface capabilities to enhance the precision and safety of ablation treatments.

Clinical Applications

Commonly used in oncology settings, the Bird Monitor Interface aids in the ablation of tumors by providing critical monitoring data. It is particularly useful in procedures requiring precise control and monitoring of ablation parameters.

Evidence Summary

The available literature includes 10 studies, encompassing various study types such as RCTs, prospective, and retrospective analyses. These studies span from 2021 to 2025, providing a comprehensive overview of the device's clinical applications.

Reported Outcomes

Published studies report that the Bird Monitor Interface enhances the accuracy of tumor ablation procedures, contributing to improved patient outcomes. The device's real-time monitoring capabilities are noted for increasing procedural safety and efficacy.

Safety Profile

Reported complications include minimal adverse events, with studies indicating a low incidence of device-related issues. The safety profile is generally favorable, with no significant complications directly attributed to the device.

Evidence Limitations

The evidence is limited by the relatively small sample sizes and the need for more long-term outcome data. Further research is needed to explore the device's efficacy across diverse patient populations and tumor types.

Frequently Asked Questions

What are the clinical indications for the Bird Monitor Interface?

The device is indicated for use in tumor ablation procedures, providing real-time monitoring to enhance precision and safety.

What outcomes have been reported in clinical studies?

Studies report improved accuracy and safety in tumor ablation procedures, with enhanced patient outcomes due to real-time monitoring.

What complications have been reported?

Safety data indicate minimal adverse events, with a low incidence of device-related complications reported in the literature.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.